Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords

Tabla de Datos

Artículos Totales: 12



# Título Código Publicación Revista Indexación Revista Tipo de Documento Autores Año
1 Effect Of Alirocumab On Lipoprotein(a) And Cardiovascular Risk After Acute Coronary Syndrome
DOI: 10.1016/J.JACC.2019.10.057
WoS: WOS:000506877300001 Journal Of The American College Of Cardiology WOS
Article 2020
2 Effects Of Alirocumab On Types Of Myocardial Infarction: Insights From The Odyssey Outcomes Trial
DOI: 10.1093/EURHEARTJ/EHZ299
WoS: WOS:000490154300015 European Heart Journal WOS
Article 2019
3 Alirocumab In Patients With Polyvascular Disease And Recent Acute Coronary Syndrome Odyssey Outcomes Trial
DOI: 10.1016/J.JACC.2019.03.013
WoS: WOS:000483334800001 Scopus: SCOPUS_ID:85066106544 Journal Of The American College Of Cardiology WOS
Scopus
Article 2019
4 Effect Of Alirocumab On Mortality After Acute Coronary Syndromes An Analysis Of The Odyssey Outcomes Randomized Clinical Trial
DOI: 10.1161/CIRCULATIONAHA.118.038840
WoS: WOS:000476768100007 Circulation WOS
Article 2019
5 Effects Of Alirocumab On Cardiovascular And Metabolic Outcomes After Acute Coronary Syndrome In Patients With Or Without Diabetes: A Prespecified Analysis Of The Odyssey Outcomes Randomised Controlled Trial
DOI: 10.1016/S2213-8587(19)30158-5
WoS: WOS:000475553300016 The Lancet Diabetes And Endocrinology WOS
Article 2019
6 Alirocumab Reduces Total Nonfatal Cardiovascular And Fatal Events The Odyssey Outcomes Trial
DOI: 10.1016/J.JACC.2018.10.039
WoS: WOS:000456818200001 Journal Of The American College Of Cardiology WOS
Article 2019
7 Alirocumab Reduces Total Hospitalizations And Increases Days Alive And Out Of Hospital In The Odyssey Outcomes Trial
DOI: 10.1161/CIRCOUTCOMES.119.005858
WoS: WOS:000502609000004 Circulation Cardiovascular Quality And Outcomes WOS
Article 2019
8 Risk Categorization Using New American College Of Cardiology/American Heart Association Guidelines For Cholesterol Management And Its Relation To Alirocumab Treatment Following Acute Coronary Syndromes
DOI: 10.1161/CIRCULATIONAHA.119.042551
WoS: WOS:000494805400011 Circulation WOS
Article 2019
9 Effects Of Alirocumab On Cardiovascular Events After Coronary Bypass Surgery
DOI: 10.1016/J.JACC.2019.07.015
WoS: WOS:000483334800002 Journal Of The American College Of Cardiology WOS
Article 2019
10 Alirocumab And Cardiovascular Outcomes After Acute Coronary Syndrome
DOI: 10.1056/NEJMOA1801174
WoS: WOS:000451402500005 Scopus: SCOPUS_ID:85057337718 New England Journal Of Medicine WOS
Scopus
Article 2018
11 Long Term Use Of Ticagrelor In Patients With Prior Myocardial Infarction
DOI: 10.1056/NEJMOA1500857
WoS: WOS:000353974700004 New England Journal Of Medicine WOS
Article 2015
12 Edoxaban Versus Warfarin In Patients With Atrial Fibrillation
DOI: 10.1056/NEJMOA1310907
WoS: WOS:000327467500007 New England Journal Of Medicine WOS
Article 2013

Descargar Descarga los datos (enriquecidos) de esta página (formato CSV).